Skip to main content

Table 1 Clinical presentation and pathological findings of the 367 patients

From: Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy

 

Overall

F.up 5 yy

F.up > 5 yy

N° of patients

367

60

307

Mean age (years), (median, range)

64.8 (66, 47-77)

64.1 (65, 49-74)

64.9 (66, 47-77)

Mean follow up (months), (median, range)

89.7 (84, 60-156)

60

95.5 (87, 61-156)

Follow up time: (years) n (%)

   

5

 

60 (16.3)

 

6-7

  

146 (39.8)

8-9

  

81 (22.1)

> 10

  

80 (21.8)

Pre-operative PSA (ng/ml)

mean (median, range)

14.6 (10.2, 0.8-87)

12.8 (9, 3.9 - 63)

15 (10.6, 0.8-87)

Pre-operative PSA (ng/ml)

n (%)

n (%)

n (%)

<10

165 (45.0)

34 (56.6)

131 (42.7)

10-20

134 (36.5)

17 (28.3)

121 (39.4)

>20

68 (18.5)

9 (15.1)

55 (17.9)

Specimen Gleason Score

n (%)

N (%)

n (%)

2-6

154 (42.0)

31 (51.7)

123 (40.1)

7

146 (39.8)

19 (31.7)

127 (41.3)

8-10

67 (18.2)

10 (16.6)

57 (18.6)

Pathological stage (TNM 1997)

n (%)

n (%)

n (%)

T2

222 (60.5)

40 (66.7)

182 (59.3)

T3a

77 (21.0)

13 (21.6)

64 (20.8)

T3b

59 (16.1)

6 (10)

53 (17.3)

T4

9 (2.4)

1 (1.7)

8 (2.6)

Nerve sparing

n (%)

n (%)

n (%)

 

125

24 (19.2)

101 (80.8)